Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,953,000 | 4,273,000 | 3,059,000 | 3,303,000 | 2,887,000 |
| Depreciation Amortization | 1,592,000 | 1,510,000 | 1,246,000 | 1,067,000 | 1,009,000 |
| Income taxes - deferred | -128,000 | -26,000 | N/A | N/A | N/A |
| Accounts receivable | -427,000 | -607,000 | N/A | N/A | N/A |
| Other Working Capital | 420,000 | 163,000 | 417,000 | 94,000 | -2,000 |
| Other Operating Activity | 493,000 | 607,000 | 164,000 | -121,000 | -3,000 |
| Operating Cash Flow | $6,903,000 | $5,920,000 | $4,886,000 | $4,343,000 | $3,891,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,523,000 | -1,767,000 | -1,460,000 | -1,391,000 | -1,373,000 |
| Net Acquisitions | -151,000 | -271,000 | -3,481,000 | -180,000 | -233,000 |
| Purchase Of Investment | -5,676,000 | -3,832,000 | N/A | N/A | N/A |
| Sale Of Investment | 4,827,000 | 3,057,000 | N/A | N/A | N/A |
| Other Investing Activity | -142,000 | -280,000 | -698,000 | -43,000 | -86,000 |
| Investing Cash Flow | $-2,665,000 | $-3,093,000 | $-5,639,000 | $-1,614,000 | $-1,692,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 814,000 | 3,208,000 | N/A | N/A | N/A |
| Debt Issued | 591,000 | 793,000 | N/A | N/A | N/A |
| Debt Repayment | -35,000 | -187,000 | N/A | N/A | N/A |
| Common Stock Issued | 387,000 | 221,000 | N/A | N/A | N/A |
| Common Stock Repurchased | -973,000 | -840,000 | N/A | N/A | N/A |
| Dividend Paid | -1,724,000 | -1,479,000 | -1,305,000 | -1,137,000 | -974,000 |
| Other Financing Activity | -1,485,000 | -4,063,000 | 1,207,000 | -782,000 | -394,000 |
| Financing Cash Flow | $-2,425,000 | $-2,347,000 | $-98,000 | $-1,919,000 | $-1,368,000 |
| Exchange Rate Effect | -47,000 | -72,000 | 25,000 | -68,000 | -21,000 |
| Beginning Cash Position | 2,512,000 | 2,104,000 | 2,753,000 | 2,011,000 | 1,201,000 |
| End Cash Position | 4,278,000 | 2,512,000 | 1,927,000 | 2,753,000 | 2,011,000 |
| Net Cash Flow | $1,766,000 | $408,000 | $-826,000 | $742,000 | $810,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,903,000 | 5,920,000 | 4,886,000 | 4,343,000 | 3,891,000 |
| Capital Expenditure | -1,689,000 | -1,822,000 | N/A | N/A | N/A |
| Free Cash Flow | 5,214,000 | 4,098,000 | 4,886,000 | 4,343,000 | 3,891,000 |